A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma
Open Access
- 1 April 2019
- journal article
- review article
- Published by Elsevier in European Journal of Cancer
- Vol. 111, 50-58
Abstract
No abstract availableKeywords
Funding Information
- North of England Children's Cancer Research (NECCR) Fund
- Great North Children's Hospital
- Masters of Clinical Research
- Newcastle Hospital Charity and Cancer Research (C8561/A12084)
- Action Medical Research & Great Ormond Street Children's Charity (GN2390)
- NECCR
This publication has 30 references indexed in Scilit:
- Ifosfamide, carboplatin, and etoposide for neuroblastomaCancer, 2012
- Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group ProjectJournal of Clinical Oncology, 2011
- Phase II Study of Irinotecan and Temozolomide in Children With Relapsed or Refractory Neuroblastoma: A Children's Oncology Group StudyJournal of Clinical Oncology, 2011
- Phase II Randomized Comparison of Topotecan Plus Cyclophosphamide Versus Topotecan Alone in Children With Recurrent or Refractory Neuroblastoma: A Children's Oncology Group StudyJournal of Clinical Oncology, 2010
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force ReportJournal of Clinical Oncology, 2009
- Topotecan, cyclophosphamide, and etoposide (TCE) in the treatment of high-risk neuroblastoma. Results of a phase-II trialJournal of Cancer Research and Clinical Oncology, 2007
- Topotecan and Etoposide in the Treatment of Relapsed High-risk NeuroblastomaJournal of Pediatric Hematology/Oncology, 2007
- Irinotecan Plus Temozolomide for Relapsed or Refractory NeuroblastomaJournal of Clinical Oncology, 2006
- Phase II Study of Temozolomide in Relapsed or Refractory High-Risk Neuroblastoma: A Joint Société Française des Cancers de l’Enfant and United Kingdom Children Cancer Study Group–New Agents Group StudyJournal of Clinical Oncology, 2006
- A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastomaCancer, 2003